| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/03/2002 | CA2412563A1 Melanocortin receptor ligands |
| 01/03/2002 | CA2412256A1 Polynucleotides and polypeptides encoded thereby |
| 01/03/2002 | CA2412024A1 Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
| 01/03/2002 | CA2411552A1 Glucagon antagonists/inverse agonists |
| 01/02/2002 | WO2002098412A1 Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid ester |
| 01/02/2002 | EP1167386A1 Canine and feline melanocortin-4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate |
| 01/02/2002 | EP1167366A1 Amine derivatives |
| 01/02/2002 | EP1167360A1 Human chymase inhibitors |
| 01/02/2002 | EP1167357A1 Alpha-substituted carboxylic acid derivatives |
| 01/02/2002 | EP1166792A2 Extracts, compounds & pharmaceutical compositions having anti-diabetic activity and their use |
| 01/02/2002 | EP1166790A1 Sugar decomposition inhibitor, digestive enzyme activity inhibitor, insulin secretion controller, and healthy food and beverage |
| 01/02/2002 | EP1166786A1 Medicinal compositions |
| 01/02/2002 | EP1166776A2 Process of preparation of solid oral dosage forms with delayed release |
| 01/02/2002 | EP1166653A2 Iron-containing protein composition |
| 01/02/2002 | EP1166652A1 Utilization of material containing docosapentaenoic acid |
| 01/02/2002 | EP1165812A2 Protozoan expression system |
| 01/02/2002 | EP1165805A1 Dsp-2 dual-specificity map kinase phosphatase |
| 01/02/2002 | EP1165788A2 Molecules of the immune system |
| 01/02/2002 | EP1165784A2 Nucleic acids including open reading frames encoding polypeptides; "orfx" |
| 01/02/2002 | EP1165781A2 Protease resistant flint analogs |
| 01/02/2002 | EP1165613A1 Melanocortin receptor ligands |
| 01/02/2002 | EP1165606A1 50 human secreted proteins |
| 01/02/2002 | EP1165603A1 Human neurogenin 3-encoding nucleotide sequences |
| 01/02/2002 | EP1165602A1 49 human secreted proteins |
| 01/02/2002 | EP1165595A1 Liver specific bile acid derivatives of the glucocorticoid antagonist ru486 |
| 01/02/2002 | EP1165561A1 6-substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents |
| 01/02/2002 | EP1165559A1 1,4-diazabicyclo 3.2.2]nonane-4-carboxylate and carboxamide derivatives, production and use thereof in therapeutics |
| 01/02/2002 | EP1165555A2 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands |
| 01/02/2002 | EP1165545A1 Novel compounds |
| 01/02/2002 | EP1165544A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase |
| 01/02/2002 | EP1165534A2 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments |
| 01/02/2002 | EP1165519A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives and their use as antidiabetics |
| 01/02/2002 | EP1165518A2 Benzimidazole and imidazolopyridine derivatives, their preparation and their use as selective modulators of bradykinin b2 (= bk-2) receptors |
| 01/02/2002 | EP1165517A1 N-benzimidazolylmethyl- and n-indolylmethyl-benzamides and their use as crf modulators |
| 01/02/2002 | EP1165516A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 01/02/2002 | EP1165514A1 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors |
| 01/02/2002 | EP1165513A1 Indolinone compounds as kinase inhibitors |
| 01/02/2002 | EP1165510A1 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders |
| 01/02/2002 | EP1165502A1 Diaryl derivatives and their use as medicaments |
| 01/02/2002 | EP1165490A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 01/02/2002 | EP1165487A1 Derivatives of venlafaxine and methods of preparing and using the same |
| 01/02/2002 | EP1165143A2 Method for expressing proteins |
| 01/02/2002 | EP1165141A2 Novel formulations comprising lipid-regulating agents |
| 01/02/2002 | EP1165135A1 Method of affecting cholesterol catabolism using nucear bile acid receptor |
| 01/02/2002 | EP1165119A1 Composition based on oppositely-charged polypeptides |
| 01/02/2002 | EP1165113A2 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES |
| 01/02/2002 | EP1165110A2 Antagonists of hmg1 for treating inflammatory conditions |
| 01/02/2002 | EP1165101A2 Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (gcs) |
| 01/02/2002 | EP1165092A1 Cyclopentanone derivatives and their use |
| 01/02/2002 | EP1165090A2 A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications |
| 01/02/2002 | EP1165089A1 Use of tianeptin in the production of medicaments to treat neurodegenerative pathologies |
| 01/02/2002 | EP1165085A1 Phthalazine derivatives for treating inflammatory diseases |
| 01/02/2002 | EP1165072A2 Valdecoxib compositions |
| 01/02/2002 | EP1164865A1 Method for selectively altering body fat level, feed efficiency, or weight gain |
| 01/02/2002 | EP1011635A4 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
| 01/02/2002 | EP0600079B1 Oral 1alpha-hydroxyprevitamin d |
| 01/02/2002 | CN1329620A Analogues of GLP-1 |
| 01/02/2002 | CN1329601A New benzimidazolone-benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 01/02/2002 | CN1329597A Pyridinium derivatives for treatment of diabetic and aging-related vascular complications |
| 01/02/2002 | CN1329593A N-substituted 2-cyanopyrrolidines |
| 01/02/2002 | CN1329589A N-aralkylaminotetralins as ligands for neuroptide YY5 receptor |
| 01/02/2002 | CN1329506A Formulation with an improved therapeutic range, cntainng nucleotide synthesis inhibitors |
| 01/02/2002 | CN1329502A Pharmaceutical compositions containing insulin |
| 01/02/2002 | CN1329493A Methods and compositions for restoring conformational stability of a protein of the p53 family |
| 01/02/2002 | CN1329491A Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants |
| 01/02/2002 | CN1329170A Preparation method of swine pancreatic island cell DNA and medicinal application for curing diabetes |
| 01/02/2002 | CN1328850A Medicine for curing diabetes |
| 01/02/2002 | CN1328839A Medicine for reducing blood pressure and cleaning fat and its production method |
| 01/02/2002 | CN1328811A Method for producing solid oral preparation form with continuous released active components |
| 01/02/2002 | CN1328780A Ultrahigh cellulose weight-reducing food |
| 01/02/2002 | CN1328779A Health-care food with function of reducing blood sugar |
| 01/02/2002 | CN1076967C Use of droloxifene for treatment of cardiovascular diseases |
| 01/01/2002 | US6335427 Component of stem bromelain |
| 01/01/2002 | US6335360 Indoline-2-carboxylic amide derivatives; obesity, eating and psychological disorders |
| 01/01/2002 | US6335353 3-hydroxypyridin-4-one derivative; iron deficiency anemia and thalassemia treatment |
| 01/01/2002 | US6335341 Anticholesterol agents; atherosclerosis |
| 01/01/2002 | US6335338 Calcilytic compounds |
| 01/01/2002 | US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis |
| 01/01/2002 | US6335327 1-benzazepine derivatives; agonists or antagonists of vasopressin and/or oxytocin |
| 01/01/2002 | US6335316 Method for administering acylated insulin |
| 01/01/2002 | US6335009 Enhancing sensitivity of cancer tumor cell to dna damaging agent or irradiation by delivering promoter linked to a poly (adp-ribose)-polymerase encoding polynucleotide |
| 01/01/2002 | CA2024849C 4-hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters, process for their preparation, their use as pharmaceuticals, and pharmaceutical preparations and precursors |
| 12/29/2001 | CA2351902A1 Use of growth hormone secretagogues for stimulating or increasing appetite |
| 12/27/2001 | WO2001098536A2 METHOD FOR ACTIVATING PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-$g(g) |
| 12/27/2001 | WO2001098512A2 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
| 12/27/2001 | WO2001098497A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof |
| 12/27/2001 | WO2001098495A1 Novel protein and dna thereof |
| 12/27/2001 | WO2001098494A1 Ligand to gpr8 and dna thereof |
| 12/27/2001 | WO2001098493A1 Insulin-like growth factor-binding protein |
| 12/27/2001 | WO2001098490A1 A g-protein coupled receptor |
| 12/27/2001 | WO2001098486A1 Mutation associated with epilepsy |
| 12/27/2001 | WO2001098355A2 Cgi-69 compositions and methods of use |
| 12/27/2001 | WO2001098353A2 Secreted proteins |
| 12/27/2001 | WO2001098351A2 G-protein coupled receptors |
| 12/27/2001 | WO2001098341A1 Novel polypeptide and its dna |
| 12/27/2001 | WO2001098332A2 Secreted redox proteins |
| 12/27/2001 | WO2001098331A2 Glucagon-like peptide-1 analogs |
| 12/27/2001 | WO2001098330A2 A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS |
| 12/27/2001 | WO2001098324A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 12/27/2001 | WO2001098323A2 G-protein coupled receptors |